CATX vs NVDA: Which Stock is Better?
Side-by-side comparison of Perspective Therapeutics Inc and Nvidia Corp in 2026
CATX
Perspective Therapeutics Inc
$2.43
NVDA
Nvidia Corp
$178.18
Key Metrics Comparison
| Metric | CATX | NVDA | Winner |
|---|---|---|---|
| Market Cap | $173.21M | $4.33T | NVDA |
| P/E Ratio | N/A | 46.07 | NVDA |
| EPS (TTM) | $N/A | $4.04 | NVDA |
| Revenue Growth | -0.4% | 0.6% | NVDA |
| Gross Margin | -5664.2% | 70.1% | NVDA |
Analyze CATX
Full quant analysis
Analyze NVDA
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is CATX or NVDA a better investment?
Comparing CATX and NVDA: Perspective Therapeutics Inc has a market cap of $173.21M while Nvidia Corp has $4.33T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between CATX and NVDA?
CATX (Perspective Therapeutics Inc) and NVDA (Nvidia Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: CATX or NVDA?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: CATX or NVDA?
NVDA has higher revenue growth at 0.6% vs -0.4% for CATX.
Which company is more profitable: CATX or NVDA?
Nvidia Corp (NVDA) has higher gross margins at 70.1% compared to -5664.2% for CATX.
Which is the larger company: CATX or NVDA?
Nvidia Corp (NVDA) is larger with a market cap of $4.33T compared to $173.21M for CATX.
Should I buy CATX or NVDA in 2026?
Both CATX and NVDA have investment merit. CATX trades at $2.43 while NVDA trades at $178.18. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between CATX and NVDA stock?
Key differences: Market Cap ($173.21M vs $4.33T), P/E Ratio (N/A vs 46.1x), Revenue Growth (-0.4% vs 0.6%), Gross Margin (-5664.2% vs 70.1%).